telehealth.helpFind my match

Home Questions Insurance, Medicare and Medicaid

Does Medicaid cover Wegovy?

Full guide: Does Medicaid cover Wegovy? Our full guide

Only in some states. Our check of all 50 states and DC (Nov 3, 2026) found 8 Medicaid programs that cover weight-loss GLP-1s with prior authorization, 2 with narrow limits and 41 that don't cover them for obesity. Every program covers them for type 2 diabetes.

Not covered in your state? Self-pay programs

How we picked

Every program here is prescribed online by a US-licensed clinician, fills prescriptions through a licensed US pharmacy and lets you start without an office visit. Each card shows the price we read on the program's own site (or says when a program prices only after its intake) and what that price covers, and we keep the date of every read; some programs bill a membership and the medication separately, and the card says so. The label on each card says what that program stands out for. How we check prices and programs.

  1. Pills or shots#1
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    • Compounded semaglutide or tirzepatide, injection or tablet
    • Medication, provider, supplies and free overnight shipping included
    • Provider review in about 24 hours, all 50 states, no membership fee
    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  2. Sale price locked in#2
    Pre-Black Friday sale: was $299

    Compounded semaglutide for $59 a month during its sale

    • Tirzepatide $109/mo; same price at every dose, every month
    • No membership, no hidden fees, cancel anytime
    • Rx written in about a day, delivered in 1-2 days

    Comes asInjection

    Semaglutide$59/moduring the pre-Black Friday sale (was $299); the page counts down to a price increase and says the sale price is locked in for life
    Visit SnagRx Read our SnagRx review
  3. Low-cost tirzepatide#3
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    • One flat rate covers every dose, with no membership fee
    • Online evaluation in about 5 minutes, no appointment needed
    • Free shipping in discreet packaging, HSA/FSA accepted

    Comes asVial

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  4. Low month-to-month#4
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    • Same price at every dose, no long contract needed
    • $89/mo semaglutide or $139/mo tirzepatide on a 12-month plan
    • Available in all 50 states

    Comes asVial or under the tongue

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  5. Overnight shipping#5
    $39 first month

    Compounded semaglutide from $97 a month

    • $39 first month on every plan, then from $97/mo on the 12-month plan; tirzepatide $39, then from $177
    • Provider review in about 24 hours; free overnight shipping
    • Full refund if a provider does not approve you; LegitScript certified

    Comes asVial

    Semaglutide from$97/moon the 12-month plan, billed monthly after a $39 first month
    Visit HealthRX Read our HealthRX review
  6. No contract#6
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    • Same price at every dose, no membership fee, cancel anytime
    • Provider review within 12 hours, ships within 24 hours
    • Tirzepatide as low as $159; all 50 states (not DC)
    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  7. Low yearly price#7
    Black Friday: 25% off at checkout

    Compounded semaglutide or tirzepatide from $96 a month on a yearly plan

    • $186/mo month to month, cancel anytime; tirzepatide is the same price
    • Same plan price at every dose
    • A licensed provider reviews every visit; unlimited care-team messaging

    Comes asVial

    Semaglutide$96/moon the 12-month plan ($1,152 billed upfront); $186 month to month
    Visit yourEra Read our yourEra review

Medicaid coverage of GLP-1s for weight loss, by state

StateMedicaid, weight lossWhat the rule saysPrograms we confirmed ship there
DelawareCovered (prior authorization)Covered with prior authorization: adults BMI >= 30, or BMI 27-30 with a weight-related condition (DMAP PA form, revised 4/2026). Fee-for-service;…8
KansasCovered (prior authorization)Covered with prior authorization for adult obesity (Saxenda, Wegovy, Zepbound) per KDHE anti-obesity criteria; KFF lists Kansas as covering (Jan 2026).8
MinnesotaCovered (prior authorization)Covered with prior authorization (Saxenda, Wegovy, Zepbound; BMI and renewal rules). A 2026 bill to end coverage (HF 4142, would start 2027) was laid over…8
MississippiCovered (prior authorization)Covered with prior authorization; adult criteria effective 7/1/2026 name Foundayo, Saxenda, Wegovy and Zepbound and require an obesity treatment plan.5
MissouriCovered (prior authorization)Covered with prior authorization; Foundayo, Zepbound and Zepbound KwikPen preferred, Wegovy non-preferred (needs a medical-necessity reason). Adults BMI >=…8
North CarolinaCovered (prior authorization)Covered with prior approval. Coverage stopped Oct 1, 2025 and was reinstated Dec 12, 2025 (NC Medicaid Direct and Managed Care). Wegovy preferred; Zepbound…8
TennesseeCovered (prior authorization)Covered with prior authorization since Aug 1, 2025 (TennCare weight management agents PA form, 08/2026); Wegovy and Zepbound preferred. MCOs add wraparound…8
WisconsinCovered (prior authorization)Covered with prior authorization. From July 1, 2026 a new weight management drug class: Foundayo and Zepbound preferred, PA required for all, one agent at a…8
MichiganLimitedSince Jan 1, 2026 (MDHHS letter L 25-73, budget cut): only for morbid obesity, after documented failure of other weight-loss treatments including preferred…8
VirginiaLimitedService authorization only (form effective 10/20/2026): BMI > 40, or > 37 with dyslipidemia, hypertension or type 2 diabetes, plus a failed trial of a…8
AlabamaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.7
AlaskaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
ArizonaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
ArkansasNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
CaliforniaNot covered for obesityMedi-Cal ended GLP-1 coverage for weight loss on Jan 1, 2026.8
ColoradoNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
ConnecticutNot covered for obesityKFF (Jan 2026, fee-for-service): covers one or more non-GLP-1 weight-loss drugs, but no GLP-1s for obesity.8
District of ColumbiaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity. (DC is included in KFF's map.)0
FloridaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
GeorgiaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
HawaiiNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
IdahoNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
IllinoisNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
IndianaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity. Indiana announced in July 2026 that it is joining the federal BALANCE model to cover Wegovy,…8
IowaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
KentuckyNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
LouisianaNot covered for obesityKFF (Jan 2026, fee-for-service): covers one or more non-GLP-1 weight-loss drugs, but no GLP-1s for obesity. Act 898 of 2026 (SB 433, effective June 9, 2026)…5
MaineNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
MarylandNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
MassachusettsNot covered for obesityMassHealth stopped covering GLP-1s and other drugs prescribed solely for weight loss in early July 2026 (MassHealth bulletin: July 3, 2026); about 22,000…8
MontanaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
NebraskaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
NevadaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
New HampshireNot covered for obesityEnded Jan 1, 2026 for prescriptions solely for weight loss. KFF notes NH still covers one or more non-GLP-1 weight-loss drugs.8
New JerseyNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
New MexicoNot covered for obesityKFF (Jan 2026, fee-for-service): covers one or more non-GLP-1 weight-loss drugs, but no GLP-1s for obesity.8
New YorkNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
North DakotaNot covered for obesityKFF (Jan 2026, fee-for-service): covers one or more non-GLP-1 weight-loss drugs, but no GLP-1s for obesity.8
OhioNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
OklahomaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
OregonNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
PennsylvaniaNot covered for obesityEnded Jan 1, 2026 for adults 21 and older (under-21 pathway kept). KFF notes PA still covers one or more non-GLP-1 weight-loss drugs.8
Rhode IslandNot covered for obesityEnded Oct 1, 2026 under the FY2027 budget: Foundayo, Saxenda, Wegovy and Zepbound no longer covered when prescribed solely for weight loss.8
South CarolinaNot covered for obesityEnded Jan 1, 2026 (coverage for Saxenda and Wegovy had started Nov 1, 2024).8
South DakotaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
TexasNot covered for obesityKFF (Jan 2026, fee-for-service): covers one or more non-GLP-1 weight-loss drugs, but no GLP-1s for obesity.8
UtahNot covered for obesityThe one-year fee-for-service pilot (July 1, 2025 to June 30, 2026) was not renewed; obesity-only coverage ended June 30, 2026 (Medicaid Information…8
VermontNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
WashingtonNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
West VirginiaNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8
WyomingNot covered for obesityKFF (Jan 2026, fee-for-service): not covered for obesity.8

Sources: each state's Medicaid pharmacy pages and KFF's Medicaid GLP-1 survey (January 2026), checked Nov 3, 2026; managed-care plans can add their own criteria. Program counts are programs we compare that state on their own site that they serve the state.

What "covered" means in Medicaid

Where Medicaid covers Wegovy or Zepbound for weight loss, it is never automatic. Expect prior authorization with a recent BMI (usually 30 or more, or 27 with a weight-related condition), sometimes proof of a diet or lifestyle program, and renewal every 6 to 12 months with proof of weight loss. Some states prefer one drug: Missouri covers Zepbound and Foundayo but not Wegovy for weight loss; Wisconsin and Tennessee list preferred products.

Managed-care plans, which cover most Medicaid members, follow the state rules but use their own forms. Ask your plan's member services for the "anti-obesity medication" criteria.

States that cut coverage in 2026

Budgets pushed several states the other way. California's Medi-Cal ended GLP-1 coverage for weight loss on January 1, 2026; Massachusetts (MassHealth) stopped in July 2026; Michigan narrowed it to severe obesity after other treatments fail. North Carolina stopped in October 2025 and brought coverage back in December. Coverage can change quickly, which is why we date every row.

If your state doesn't cover it

Medicaid still covers GLP-1s like Ozempic and Mounjaro if you have type 2 diabetes, so mention that diagnosis if it applies. Otherwise the realistic route is self-pay. Compounded semaglutide starts at $59 a month and compounded tirzepatide at $96 at the programs we compare (Nov 12, 2026); month to month, the lowest semaglutide is $59 at SnagRx. Several accept HSA or FSA cards.

Check that the program ships to your state first: a few skip Louisiana, Mississippi or Alabama because of state rules on compounded GLP-1s. The table above counts the programs we confirmed for each state.

Compare the programs Find my match